CPH Gut Microbiome Hub

Over the past twenty years, the gut microbiome has gained recognition as a significant factor in human health, leading to the development of innovative solutions focused on improving gut health. Looking back at the obstacles encountered ten or more years ago, when scientists and companies found it difficult to gather enough scientific support for their probiotic products to secure health claims from the European Food Safety Authority (EFSA), reminds us of the importance of learning from past experiences.

BaseClear speaker: Dr. Eline Klaassens, Product Manager Human Microbiome

Title of presentation: Application of omics analysis for microbiome innovations

Time of presentation: May 27. 15:20

Location: Medicon Valley Alliance, Copenhagen, Denmark

Date: May 27, 2024, 12:30-16:30


Microbiome & Probiotics R&D and Business Collaboration Forum

Last year, this conference drew the participation of 265 leaders from industry, academia, and investment sectors, fostering in-depth conversations on the latest advancements in microbiome, probiotics, and skin-based research. As silver sponsors of this event, please visit us at stand 19 to learn more about our expertise.

BaseClear speaker: Dr. Eline Klaassens, Product Manager Human Microbiome

Title of presentation: Using omics techniques to analyse the microbiome in clinical samples

Time of presentation: Day 1, April 23. 14:25-14:40

Location: The Postillion Convention Centre, The Hague, The Netherlands
Stand: 19

Date:  April 23 – 24, 2024


Microbes in Women's Health Congress

Historically, women’s health has been a neglected area in medical research, lacking sufficient attention and funding. Nonetheless, there is a growing acknowledgment of the significant gaps in research and treatments within this domain. Microbiome studies offer potential solutions to address some of these deficiencies. Ranging from examining the vaginal microbiome’s role in reproductive health to exploring how menopause affects the skin microbiome, the applications of microbiome science in women’s health are extensive, offering a chance to create innovative treatments and diagnostic tools.

Location: Copenhagen, Denmark

Date: April 9 – 11, 2024


Pharmabiotics 2024

Developing new therapeutic and diagnostic technologies based on microbiome science presents great challenges, beginning as early as the lab all the way to validating clinical trials and commercialization: microbiome-based biomarkers and diagnostic tools, animal-free models and their validation, data, AI and machine learning, and the latest microbiome regulatory science updates in a shifting landscape to give you and your partners a better vision for your development choices.

We were one of the sponsors of this event, which provided great insights to our BaseClear team, leveraging the latest in microbiome-based medicinal product research and development and engaging with other innovators and stakeholders in the field.

Location: Lille, France

Date: March 12 – 14, 2024


Metabolomics & Fermentative Food Products

This was the second meeting, which was held at Danone Research & Innovation in Utrecht, the Netherlands, was a follow-up meeting to broaden our knowledge and network in the field of Metabolomics and Fermented Foods. With a primary emphasis on mammalian health and food production, this event provided a platform for knowledge-sharing and networking opportunities.

As sponsors of this event, we seized the opportunity to cultivate new collaborations with fellow industry experts in the field of fermentative food production.

Location: Danone Research & Innovation, Utrecht, the Netherlands

Date: February 29, 2024

Get in touch